Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Sy Mukherjee
Sy Mukherjee is a former health care reporter for
Fortune.
Page 22 of 100
Newsletters
Nestlé invests another $200 million in Aimmune’s peanut allergy drug
By
Sy Mukherjee
Health
The Gates Foundation is pledging up to $100 million for the fight against coronavirus
By
Sy Mukherjee
Newsletters
What Andreessen’s ‘Bio Fund III’ means for healthcare
By
Sy Mukherjee
Newsletters
A vaccine that looked promising for HIV doesn’t work
By
Sy Mukherjee
Health
The first coronavirus drug candidate is set for testing in China
By
Sy Mukherjee
Health
For what ails Super Bowl athletes? Former NFL player talks up a new long-lasting knee treatment
By
Sy Mukherjee
Newsletters
Vertex CEO takes an earnings victory lap right before he exits
By
Sy Mukherjee
Newsletters
Eli Lilly smashed Wall Street projections thanks to its diabetes drugs
By
Sy Mukherjee
Health
How the Wuhan coronavirus spreads and what’s being done about it
By
Sy Mukherjee
Newsletters
Why a drug that costs $2.1 million per dose is on a sales streak
By
Sy Mukherjee
Newsletters
One drug, one patent?
By
Sy Mukherjee
Health
Michael Bloomberg’s radical plan to cut prescription drug costs
By
Sy Mukherjee
Newsletters
Kobe Bryant and the science of grief
By
Sy Mukherjee
Newsletters
The hunt for a coronavirus vaccine begins
By
Sy Mukherjee
Health
Telehealth startup Ro partners with Pfizer to give its ED business a boost
By
Sy Mukherjee